“Programmed Polymeric Devices” for Pulsed Drug Delivery
暂无分享,去创建一个
Stefaan C. De Smedt | S. D. De Smedt | J. Demeester | Barbara G. Stubbe | Joseph Demeester | B. Stubbe
[1] J L Cleland,et al. Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing response. , 1998, Journal of pharmaceutical sciences.
[2] S. Mitragotri,et al. Frequency Dependence of Sonophoresis , 2001, Pharmaceutical Research.
[3] J. Heller,et al. Pulsatile and delayed release of lysozyme from ointment-like poly(ortho esters) , 1992 .
[4] W. Hennink,et al. Delayed release of a model protein from enzymatically-degrading dextran hydrogels , 1997 .
[5] N. Yui,et al. Pulsatile peptide release from multi-layered hydrogel formulations consisting of poly(ethylene glycol)-grafted and ungrafted dextrans. , 1999, Journal of biomaterials science. Polymer edition.
[6] T. Wrin,et al. Development of a single-shot subunit vaccine for HIV-1. 3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120. , 1996, Journal of pharmaceutical sciences.
[7] M. Brandon,et al. In vitro testing of a pulsatile delivery system and its in vivo application for immunisation against tetanus toxoid , 1997 .
[8] T. Okano,et al. Time-programmed pulsatile release of dextran from calcium-alginate gel beads coated with carboxy-n-propylacrylamide copolymers. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[9] N. Yui,et al. Hyaluronic acid grafted with poly(ethylene glycol) as a novel peptide formulation. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[10] K. Zhu,et al. Pulsatile protein release from a laminated device comprising polyanhydrides and pH-sensitive complexes. , 2000, International journal of pharmaceutics.
[11] B. Gander,et al. Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres. , 1996, Vaccine.
[12] E. Edelman,et al. Optimization of release from magnetically controlled polymeric drug release devices. , 1993, Biomaterials.
[13] Y. Tokunaga,et al. In vivo performance of time-controlled explosion system (TES) in GI physiology regulated dogs , 1998 .
[14] T. Park,et al. Determinants of Release Rate of Tetanus Vaccine from Polyester Microspheres , 1993, Pharmaceutical Research.
[15] J. Heller. Modulated release from drug delivery devices. , 1993, Critical reviews in therapeutic drug carrier systems.
[16] M. Lawrence,et al. Formulation of electrically conducting microemulsion-based organogels. , 2003, International journal of pharmaceutics.
[17] A. D'emanuele,et al. On-off transport through a thermoresponsive hydrogel composite membrane. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[18] Hans P. Merkle,et al. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres : importance of polymer degradation and antigen release for immune response , 1996 .
[19] Sakurai Yasuhisa,et al. Regulated release of drug microspheres from inflammation responsive degradable matrices of crosslinked hyaluronic acid , 1993 .
[20] R K Gupta,et al. Pulsed controlled-released system for potential use in vaccine delivery. , 1996, Journal of pharmaceutical sciences.
[21] B. Gander,et al. A contribution to overcoming the problem of residual solvents in biodegradable microspheres prepared by coacervation , 1996 .
[22] K. Zhu,et al. Design of a core-shelled polymer cylinder for potential programmable drug delivery. , 2001, International journal of pharmaceutics.
[23] Donald L. Wise,et al. Design of capsules that burst at predetermined times by dialysis , 1992 .
[24] J L Cleland,et al. Development of a single-shot subunit vaccine for HIV-1. 2. Defining optimal autoboost characteristics to maximize the humoral immune response. , 1996, Journal of pharmaceutical sciences.
[25] Sakurai Yasuhisa,et al. Inflammation responsive degradation of crosslinked hyaluronic acid gels , 1992 .
[26] W. Hennink,et al. Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[27] R. Langer,et al. Enzymatically activated microencapsulated liposomes can provide pulsatile drug release , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] S. Schwendeman,et al. Stabilization of Proteins Encapsulated in Cylindrical Poly(lactide-co-glycolide) Implants: Mechanism of Stabilization by Basic Additives , 2000, Pharmaceutical Research.
[29] J L Cleland,et al. Development of a single-shot subunit vaccine for HIV-1. , 1997, AIDS research and human retroviruses.
[30] Ronald A Siegel,et al. New mode of drug delivery: long term autonomous rhythmic hormone release across a hydrogel membrane. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[31] Richard W. Baker,et al. Osmotic drug delivery : a review of the patent literature , 1995 .
[32] A. Göpferich,et al. Programmable biodegradable implants. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[33] Wim E. Hennink,et al. Controlled Release of Liposomes from Biodegradable Dextran Microspheres: A Novel Delivery Concept , 2000, Pharmaceutical Research.
[34] F. Horkay,et al. Swelling Pressure Observations on Degrading Dex-HEMA Hydrogels , 2002 .
[35] R. Baker,et al. Controlled Release Delivery Systems , 1986 .
[36] R Langer,et al. Responsive polymeric delivery systems. , 2001, Advanced drug delivery reviews.
[37] D Needham,et al. Lipid-coated microgels for the triggered release of doxorubicin. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[38] A. Göpferich,et al. Bioerodible implants with programmable drug release , 1997 .
[39] F. Patat,et al. Effect of sonication parameters on transdermal delivery of insulin to hairless rats. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[40] T. Okano,et al. Effect of Ca2+-alginate gel dissolution on release of dextran with different molecular weights. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[41] T. Uchida,et al. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. , 1996, Chemical & pharmaceutical bulletin.
[42] A. Straughn,et al. Pharmacokinetics of Methylphenidate After Oral Administration of Two Modified-Release Formulations in Healthy Adults , 2003, Clinical pharmacokinetics.
[43] Ajay K Banga,et al. Electrically enhanced transdermal delivery of a macromolecule , 2002, The Journal of pharmacy and pharmacology.
[44] J. Kost. Pulsed and Self-Regulated Drug Delivery , 1990 .
[45] T. Aminabhavi,et al. Stimulus-Responsive “Smart” Hydrogels as Novel Drug Delivery Systems , 2002, Drug development and industrial pharmacy.
[46] Michael R Powell. Drug Delivery Issues in Vaccine Development , 1996, Pharmaceutical Research.
[47] R. Langer,et al. Predicting drug release from cylindric polyanhydride matrix discs , 1995 .
[48] S. Tanna,et al. A Covalently Stabilised Glucose Responsive Gel Formulation with a Carbopol ® Carrier , 2002, Journal of drug targeting.
[49] S. Schwendeman,et al. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.
[50] A. Göpferich,et al. Mechanisms of polymer degradation and erosion. , 1996, Biomaterials.
[51] J. Mcghee,et al. Biodegradable microspheres as a vaccine delivery system. , 1991, Molecular immunology.
[52] Walter J. Murphy. CHEMICAL AND ENGINEERING NEWS: State Science , 1948 .
[53] W. Hennink,et al. Controlled release of a model protein from enzymatically degrading dextran microspheres. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[54] S. Ueda,et al. Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design. , 1994, Journal of drug targeting.
[55] F. Horkay,et al. Tailoring the swelling pressure of degrading dextran hydroxyethyl methacrylate hydrogels. , 2003, Biomacromolecules.